Dr. Ettinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964- Is this information wrong?
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1973 - 1975
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1968 - 1971
Albany Medical CenterInternship, Transitional Year, 1967 - 1968
University of Louisville School of MedicineClass of 1967
Certifications & Licensure
MD State Medical License 1974 - 2024
DC State Medical License 2013 - 2020
MN State Medical License 1968 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Start of enrollment: 1994 Mar 01
- Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma Start of enrollment: 1998 Oct 13
- Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall Start of enrollment: 2004 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC.Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J F...> ;Cancer Research Communications. 2024 Mar 14
- 1 citationsElucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.Murray, J., Sivapalan, L., Hummelink, K., Balan, A., White, J., Niknafs, N., Rhymee, L., Pereira, G., Rao, N., Weksler, B., Bahary, N., Phallen, J., Leal, A., Bartlett...> ;Clinical Cancer Research. 2024 Jan 17
- Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non-Small-Cell Lung Cancer.Paola Ghanem, Joseph C Murray, Melinda Hsu, Matthew Z Guo, David S Ettinger, Josephine Feliciano, Patrick Forde, Christine L Hann, Vincent K Lam, Benjamin Levy, Valsam...> ;Clinical Lung Cancer. 2024 Mar 1
- Join now to see all
Press Mentions
PD-L1 Inhibitor Avelumab May Improve Survival in Metastatic Urothelial CarcinomaOctober 7th, 2015- Dr David Ettinger Discusses the Road Ahead for Immunotherapy in NSCLCOctober 6th, 2015
Grant Support
- Eastern Cooperative Oncology GroupNational Cancer Institute1985–1992
Professional Memberships
- Member
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/david-ettinger
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
